Back to Two Sigma Investments, LP Two Sigma Investments, LP

NTLANTLA

Showing 8 of 31 quarters

Position history for Two Sigma Investments, LPTwo Sigma Investments, LP's holdings in Intellia Therapeutics, Inc.

Yes. Two Sigma Investments holds 5,235,348 shares of NTLA (Intellia Therapeutics), worth $88.6M, as of its Q2 2026 13F filing. It increased the position by 529,447 shares (+11.3%) from Q1 2026. Two Sigma Investments has held NTLA since Q2 2019, across 29 quarterly 13F filings. NTLA is 0.1% of Two Sigma Investments' reported 13F portfolio.

Current Value

$88.6M

Current Shares

5.2M

Total Value Change

+$68.4M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.2M
+11.3%
$88.6M0.1%$16.92
33
2026-Q1
Increased
4.7M
+74.4%
$60.3M0.0%$12.82
44
2025-Q4
Increased
2.7M
+10.2%
$24.3M0.0%$8.99
32
2025-Q3
Increased
2.4M
+7.6%
$42.3M0.1%$17.27
31
2025-Q2
Increased
2.3M
+14.2%
$21.4M0.0%$9.38
32
2025-Q1
Increased
2M
+8.1%
$14.2M0.0%$7.11
30
2024-Q4
Increased
1.8M
+88.1%
$21.5M0.0%$11.66
45
2024-Q3
Increased
980,380
+18.2%
$20.1M0.0%$20.55
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used